118 related articles for article (PubMed ID: 2143776)
1. Diminished response to recombinant hepatitis B vaccine in homosexual men with HIV antibody: an indicator of poor prognosis.
Loke RH; Murray-Lyon IM; Coleman JC; Evans BA; Zuckerman AJ
J Med Virol; 1990 Jun; 31(2):109-11. PubMed ID: 2143776
[TBL] [Abstract][Full Text] [Related]
2. Impaired response to recombinant hepatitis B vaccine in HIV-infected persons.
Bruguera M; Cremades M; Salinas R; Costa J; Grau M; Sans J
J Clin Gastroenterol; 1992 Jan; 14(1):27-30. PubMed ID: 1532609
[TBL] [Abstract][Full Text] [Related]
3. Active immunization of homosexual men using a recombinant hepatitis B vaccine.
Hess G; Rossol S; Voth R; Cheatham-Speth D; Clemens R; Meyer zum Büschenfelde KH
J Med Virol; 1989 Dec; 29(4):229-31. PubMed ID: 2576035
[TBL] [Abstract][Full Text] [Related]
4. Protective efficacy of a recombinant DNA vaccine against hepatitis B in male homosexuals: results at 36 months.
Goilav C; Prinsen H; Piot P
Vaccine; 1990 Mar; 8 Suppl():S50-2; discussion S60-2. PubMed ID: 2139284
[TBL] [Abstract][Full Text] [Related]
5. Comparative immunogenicity of plasma and recombinant hepatitis B virus vaccines in homosexual men.
Odaka N; Eldred L; Cohn S; Muñoz A; Fields HA; Fox R; Solomon R; Kaslow R; Polk BF
JAMA; 1988 Dec 23-30; 260(24):3635-7. PubMed ID: 2973531
[TBL] [Abstract][Full Text] [Related]
6. Antibody responses to intradermal recombinant hepatitis B immunization among HIV-positive subjects.
Ristola MA; Vuola JM; Valle M; von Reyn CF
Vaccine; 2004 Nov; 23(2):205-9. PubMed ID: 15531038
[TBL] [Abstract][Full Text] [Related]
7. Antibody to human immunodeficiency virus (HIV) and suboptimal response to hepatitis B vaccination.
Collier AC; Corey L; Murphy VL; Handsfield HH
Ann Intern Med; 1988 Jul; 109(2):101-5. PubMed ID: 2968064
[TBL] [Abstract][Full Text] [Related]
8. Intradermal vaccination of adults with three low doses (2 micrograms) of recombinant hepatitis B vaccine. II. Persistence of immunity and induction of immunologic memory.
Elisbão Mdo C; Baldy JL; Bonametti AM; Reiche EM; Morimoto HK; Pontello R; Matsuo T; Ferelle A; Neves J
Mem Inst Oswaldo Cruz; 2003 Dec; 98(8):1109-13. PubMed ID: 15049099
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of a yeast-recombinant hepatitis B vaccine in high-risk children.
Rumi MG; Romeo R; Bortolini M; Gringeri A; Zanetti AR; Mannucci PM; Colombo M
J Med Virol; 1989 Jan; 27(1):48-51. PubMed ID: 2522146
[TBL] [Abstract][Full Text] [Related]
10. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.
Shafran SD; Mashinter LD; Lindemulder A; Taylor GD; Chiu I
HIV Med; 2007 Jul; 8(5):295-9. PubMed ID: 17561875
[TBL] [Abstract][Full Text] [Related]
11. Antibody response to hepatitis B immunization in infants born to HIV-infected mothers.
Thaithumyanon P; Punnahitananda S; Praisuwanna P; Thisyakorn U; Ruxrungtham K
J Med Assoc Thai; 2002 Mar; 85(3):277-82. PubMed ID: 12117014
[TBL] [Abstract][Full Text] [Related]
12. Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies.
Gandhi RT; Wurcel A; Lee H; McGovern B; Shopis J; Geary M; Sivamurthy R; Sax PE; Ukomadu C
J Infect Dis; 2005 May; 191(9):1435-41. PubMed ID: 15809901
[TBL] [Abstract][Full Text] [Related]
13. Long-term immunogenicity of a plasma-derived hepatitis B vaccine in HIV seropositive and HIV seronegative hemophiliacs.
Mannucci PM; Zanetti AR; Gringeri A; Tanzi E; Morfini M; Messori A; Tirindelli MC; de Biasi R; Ciavarella N; Colombo M
Arch Intern Med; 1989 Jun; 149(6):1333-7. PubMed ID: 2525013
[TBL] [Abstract][Full Text] [Related]
14. [The immunogenicity of the hepatitis B vaccine in drug addicts with human immunodeficiency virus infection].
Menicagli V; Barbanera M; Menicagli S
Recenti Prog Med; 1991 Feb; 82(2):69-71. PubMed ID: 2034870
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two immunization schedules with recombinant hepatitis B vaccine and natural immunity acquired by hepatitis B infection in dialysis patients.
el-Reshaid K; al-Mufti S; Johny KV; Sugathan TN
Vaccine; 1994; 12(3):223-34. PubMed ID: 8165854
[TBL] [Abstract][Full Text] [Related]
16. Lack of response to recombinant hepatitis B vaccine in nonresponders to the plasma vaccine.
Weissman JY; Tsuchiyose MM; Tong MJ; Co R; Chin K; Ettenger RB
JAMA; 1988 Sep 23-30; 260(12):1734-8. PubMed ID: 2970557
[TBL] [Abstract][Full Text] [Related]
17. Persistence of antibodies following vaccination with a yeast-derived recombinant hepatitis B vaccine.
Just M; Berger R; Scheiermann N
Vaccine; 1988 Oct; 6(5):401-2. PubMed ID: 2973694
[TBL] [Abstract][Full Text] [Related]
18. [Anti-HBs persistence after revaccination with three doses of hepatitis B vaccines among non-responsive adults: 24-month of follow-up].
Zhang L; Lyu J; Yan B; Liu J; Feng Y; Chen S; Zhou L; Liang X; Cui F; Wang F; Xu A
Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Sep; 49(9):782-7. PubMed ID: 26733135
[TBL] [Abstract][Full Text] [Related]
19. [Results of vaccination with the hepatitis B vaccine in patients and personnel at the Hemodialysis Center in Karlovac].
Palmović D; Vitas B; Doko A; Belavić Z; Racki L
Lijec Vjesn; 1989 Nov; 111(11):400-4. PubMed ID: 2534601
[TBL] [Abstract][Full Text] [Related]
20. Complete seroconversion by low-dose intradermal injection of recombinant hepatitis B vaccine in hemodialysis patients.
Ono K; Kashiwagi S
Nephron; 1991; 58(1):47-51. PubMed ID: 1830374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
